0001453687-23-000081.txt : 20231115
0001453687-23-000081.hdr.sgml : 20231115
20231115171452
ACCESSION NUMBER: 0001453687-23-000081
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231113
FILED AS OF DATE: 20231115
DATE AS OF CHANGE: 20231115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COX CARRIE SMITH
CENTRAL INDEX KEY: 0001110753
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37798
FILM NUMBER: 231411545
MAIL ADDRESS:
STREET 1: SCHERING-PLOUGH CORPORATION
STREET 2: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cartesian Therapeutics, Inc.
CENTRAL INDEX KEY: 0001453687
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-923-1400
MAIL ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: SELECTA BIOSCIENCES INC
DATE OF NAME CHANGE: 20090109
4
1
wk-form4_1700086481.xml
FORM 4
X0508
4
2023-11-13
0
0001453687
Cartesian Therapeutics, Inc.
RNAC
0001110753
COX CARRIE SMITH
C/O CARTESIAN THERAPEUTICS, INC.
65 GROVE STREET
WATERTOWN
MA
02472
1
0
0
0
0
Stock Option (Right to Buy)
1.32
2023-11-13
4
D
0
20000
0.74
D
2029-11-19
Common Stock
20000
0
D
Stock Option (Right to Buy)
3
2023-11-13
4
D
0
30000
D
2030-06-18
Common Stock
30000
0
D
Stock Option (Right to Buy)
4.01
2023-11-13
4
D
0
60000
D
2031-03-29
Common Stock
60000
0
D
Stock Option (Right to Buy)
3.31
2023-11-13
4
D
0
60000
D
2032-01-02
Common Stock
60000
0
D
Stock Option (Right to Buy)
1.13
2023-11-13
4
D
0
107500
0.93
D
2033-01-01
Common Stock
107500
0
D
This option, which provided for vesting in thirty-six (36) substantially equal monthly installments over three years following the date of grant on November 20, 2019, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc. in exchange for a cash payment of $14,800, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger.
This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger.
This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger.
This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $99,975, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
Matthew Bartholomae, Attorney-in-Fact for Carrie Smith Cox
2023-11-15